Amneal Pharmaceuticals
Manufacturing · New Jersey, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
400 Crossing Blvd Fl 3, Bridgewater, New...Phone Number
(908) 947-3120Website
www.amneal.comRevenue
$3.1 BillionStock Symbol
AMRXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
2
1
1
About Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomesRead more
Amneal Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amneal Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Amneal Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Amneal Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Amneal Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check out if Amneal Pharmaceuticals is spiking on competitors!
Amneal Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Amneal Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Amneal Pharmaceuticals has new funding data
Earning: See what the market has to say on Amneal Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Amneal Pharmaceuticals as Masked Content
Find more new buyers
Explore company insights
Get a deeper look into Amneal Pharmaceuticals's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Amneal Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amneal Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amneal Pharmaceuticals.
Amneal Pharmaceuticals financials insights
Gather financial insights about Amneal Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$250M
Amneal Pharmaceuticals Tech Stack
A closer look at the technologies used by Amneal Pharmaceuticals
Most Recent Scoops
Hiring Plans
Amneal Pharmaceuticals has more open roles in Operations than it has had at any time in the past 12 months with an increased focus on technologies like SAP ERP, and experience with GPS, Circuit, JD Edwards EnterpriseOne, SAP S/4HANA, SAP, and SAP Ariba. Areas of expertise include: Manufacturing Operations, Standard Operating Procedures Development, Preventive Maintenance, Equipment Operation, Salesforce API, Dryers, and Root Cause Analysis.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
Amneal Pharmaceuticals News & Media
5 Defensive Stocks to Buy as Consumer Confidence Hits 7-Month Low
COCO, DAR, CNC, EXC and AMRX offer a defensive appeal as consumer confidence hits a 7-month low amid inflation and labor market concerns.Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercializationAmneal Pharmaceuticals, Inc. (AMRX) Q2 2026 Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2026 Earnings Call July 30, 2026 8:30 AM EDTCompany ParticipantsAnthony DiMeo - Head/VP of Investor RelationsChirag...Amneal Reports Second Quarter 2026 Financial Results
– Q2 2026 Net Revenue of $796 million; GAAP Net Income of $58 million; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million; Adjusted Diluted EPS of $0.30 – – Raising 2026 Full Year Guidance – – Successful Debt Repricing in July Reduces Interest Cost –
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amneal Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-dr... Read More
